Generation of nitric oxide and clearance of interferon-γ after BCG infection are impaired in mice that lack the interferon-γ receptor

Journal of Inflammation

Volumn 46, Issue 1, 1996, Pages 23-31

  Kamijo, Ryutaro ^a   Gerecitano, John ^b   Shapiro, Deborah ^c   Green, Shawn J ^d   Aguet, Michel ^e   Le, Dimming ^f   Vilcek, Jan ^g  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b ENTREMED INC   (United States)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d NEW YORK UNIVERSITY   (United States)

^e SHOWA UNIVERSITY   (Japan)

^f Rockland Pulmonary Associates   (United States)

^g GENENTECH INC   (United States)

Author keywords

host resistance; interferon ; macrophages; Mycobacterium bovis; nitrite nitrate; tumor necrosis factor

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERFERON RECEPTOR; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE DELETION; IMMUNOREGULATION; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUBERCULOSIS;

ANIMALS; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUTATION; MYCOBACTERIUM BOVIS; NITRATES; NITRIC OXIDE; NITRITES; RECEPTORS, INTERFERON; SPLEEN; TUBERCULOSIS;

EID: 0029880579     PISSN: 10787852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA: Multiple defects of immune cell function in mice with disrupted interferon-y genes. Science 259:1739-1742, 1993.
2. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel RM, Aguet M: Immune response in mice that lack the interferon-y receptor. Science 259:1742-1745, 1993.
3. Kamijo R, Le J, Shapiro D, Havell EA, Huang S, Aguet M, Bosland M, Vilcek J: Mice that lack the interferony receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. J Exp Med 178: 1435-1440, 1993.
4. Flynn JL, ~Chan J, Ttiebold KJ, Dalton DK, Stewart TA, Bloom BR: An essential role for interferon-y in resistance to Mycobacterium tuberculosis infection. J Exp Med 178:2249-2254, 1993.
5. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM: Disseminated tuberculosis in IFNy genedisrupted mice. J Exp Med 178:2243-2247, 1993.
6. Kindler V, Sappino A-P, Grau GE, Piguet P-F, Vassalli P: The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731-740, 1989.
7. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW, Bloom BR: Tumor necrosis factor-a is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561-572, 1995.
8. Denis M: Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell Immunol 132:150-157, 1991.
9. Chan J, King Y, Magliozzo RS, Bloom BR: Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 175:1111-1122, 1992.
10. Ding AH, Nathan CF, Stuehr DJ: Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 141:2407-2412, 1988.
11. Stuehr DJ, Marietta MA: Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma. J Immunol 139:518-525, 1987.
12. Green SJ, Meltzer MS, Hibbs JB Jr, Nacy CA: Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol 144:278-283, 1990.
13. Green SJ, Nacy CA, Schreiber RD, Granger DL, Crawford RM, Meltzer MS, Portier AH: Neutralization of gamma interferon and tumor necrosis factor alpha blocks in vivo synthesis of nitrogen oxides from Larginine and protection against Franc/sella tularensis infection in Mycobacterium bovis BCG-treated mice. Infect Immun 61:689-698, 1993.
14. Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, Shapiro D, Le J, Koh SI, Kimura T, Green SJ, Mak TW, Taniguchi T, Vilcek J: Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263:1612-1615, 1994.
15. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
16. Blanden RV, Lefford MJ, Mackaness GB: The host response to Calmette-Guérin Bacillus infection in mice. J Exp Med 129:1079-1107, 1969.
17. Kamijo R, Shapiro D, Le J, Huang S, Aguet M, Vilcek J: Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon y receptor. Proc Natl Acad Sci USA 90:6626-6630, 1993.
18. Granger DL, Hibbs JB Jr, Broadnax LM: Urinary nitrate excretion in relation to murine macrophage activation. Influence of dietary L-arginine and oral NG-monomethyl-L-arginine. J Immunol 146:1294-1302, 1991.
19. Cockfield SM, Ramassar V, Noujaim J, van der Meide PH, Halloran PF: Regulation of IFN-y expression in vivo. IFN-y up-regulates expression of its mRNA in normal and lipopolysaccharide-stimulated mice. J Immunol 150:717-725, 1993.
20. Hardy KJ, Sawada T: Human y interferon strongly upregulates its own gene expression in peripheral blood lymphocytes. J Exp Med 170:1021-1026, 1989.
21. Di Marzio P, Puddu P, Conti L, Belardelli F, Gessani S: Interferon y upregulates its own gene expression in mouse peritoneal macrophages. J Exp Med 179:17311736, 1994.
22. Belosevic M, Davis CE, Meltzer MS, Nacy CA: Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFNy for induction of resistance to infection. J Immunol 141:890-896, 1988.
23. Nathan CF, Murray HW, Wiebe ME, Rubin BY: Identification of interferon-y as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 158:670-689, 1983.
24. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-3064, 1992.
25. Nathan C, Xie Q-W: Nitric oxide synthases: Roles, tolls, and controls. Cell 78:915-918, 1994.
26. Xie Q-W, Kashiwabara Y, Nathan C: Role of transcription factor NF-KB/Rel in induction of nitric oxide synthase. J Biol Chem 269:4705-4708, 1994.
27. Martin E, Nathan C, Xie Q-W: Role of Interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med 180: 977-984, 1994.
28. Narumi S, Tebo JM, Finke JH, Hamilton TA: IFN-y and IL-2 cooperatively activate NF-icB in murine peritoneal macrophages. J Immunol 149: 529-534, 1992.
29. Wolchok JD, Goodman AR, Vilcek J: Activation of NFKB may be necessary but is not sufficient for induction of H-2 antigens by TNF in J558L murine myeloma cells. J Leuk Biol 55: 7-12, 1994.
30. Smith MR, Muegge K, Keller JR, Kung H-F, Young HA, Durum SK: Direct evidence for an intracellular role for IFN-y. Microinjection of human IFN-y induces la expression on murine macrophages. J Immunol 144:1777-1782, 1990.
31. De Maeyer E, De Maeyer-Guignard J: "Interferons and Other Regulatory Cytokines." New York: John Wiley & Sons, 1988.
32. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B: An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666-3670, 1975.
33. Graham MB, Dalton DK, Giltinan D, Braciale VL, Stewart TA, Braciale TJ: Response to influenza infection in mice with a targeted disruption in the Interferon y gene. J Exp Med 178:1725-1732, 1993.
34. Scott P: IFN-y modulates the early development of Th, and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol 147:3149-3155, 1991.
35. Wang ZE, Reiner SL, Zheng S, Dalton DK, Locksley RM: CD4+ effector cells default to the Th2 pathway in Interferon y-deficient mice infected with Leishmania major. J Exp Med 179:1367-1371, 1994.
36. Schijns VECJ, Haagmans BL, Rijke EO, Huang S, Aguet M, Horzinek MC: IFN-y receptor-deficient mice generate antiviral Th, -characteristic cytokine profiles but altered antibody responses. J Immunol 153:2029-2037, 1994.
37. Swihart K, Fruth U, Messmer N, Hug K, Behin R, Huang S, Del Giudice G, Aguet M, Louis JA: Mice from a genetically resistant background lacking the Interferon y receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response. J Exp Med 181: 961-971, 1995.
38. Anderson P, Yip YK, Vilcek J: Human interferon-y is internalized and degraded by cultured fibroblasts. J Biol Chem 258:6497-6502, 1983.
39. Novick D, Engelmann H, Wallach D, Rubinstein M: Soluble cytokine receptors are present in normal human urine. J Exp Med 170:1409-1414, 1989.
40. Erickson SL, de Sauvage FJ, Kikly K, Carver-Moore K, Pitts-Meek S, Gillett N, Sheehan KG, Schreiber RD, Goeddel DV, Moore MW: Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372: 560-563, 1994.